Cardiol Therapeutics Inc
Cardiol Therapeutics Inc (CRDL) Option Chain
Read more
Tracking the CRDL option chain helps you see every strike and expiry on Cardiol Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRDL options activity at a glance. Use our scanner to monitor the CRDL option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRDL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CRDL options are being actively traded, and where they are not.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 100.00 | 2 | 0 | 0.10 | 0.50 | 0.10 | 1.10 | 0.50 | -50.00 | — | 0.05 | 0.00 | 0.05 | 0 | 0 | 0.00 |
| 100.00 | 29 | 0 | 1.00 | 0.00 | — | 1.00 | 1.00 | 0.00 | — | 0.35 | 0.00 | 0.35 | 0 | 19 | 0.00 |
| 100.00 | 4 | 0 | 0.55 | 0.00 | — | 0.55 | 1.50 | +50.00 | 0.10 | 1.10 | 0.50 | 0.10 | 0 | 0 | 0.00 |
| 100.00 | 10 | 0 | 0.05 | 0.00 | — | 0.05 | 2.00 | +100.00 | 0.50 | 1.50 | 1.00 | 0.00 | 0 | 0 | 0.00 |
| 100.00 | 10 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +150.00 | 1.05 | 2.05 | 1.50 | 0.05 | 0 | 0 | 0.00 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV Rank100.00% High
- Market cap (M$)121
- 52 weeks high-57.26%
- 52 weeks low13.64%
- Analyst recommendationStrong Buy
1.00 - Target price$7.89
689.00% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E—
- Future P/E—
- EPS (ttm)-0.24
- EPS growth next 5 years61.01%
As of Nov 13, 2026